Abstract
Guillain-Barre syndrome (GBS) is described by a wide range of motor impairment, flaccidity, hyporeflexia, and progressive and ascending flaccid paralysis. Group B Streptococcus, also known as Streptococcus agalactia and Campylobacter jejuni, are Gram-positive bacteria also known as the leading cause of GBS; its variants are acute motor axonal neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN), acute inflammatory demyelinating neuropathy (AIDP), and Miller-Fisher syndrome (MFS). A 20-year-old girl came with complaints of generalized weakness, fever and pain over the lower limb. Huges (GBS disability scale) and the Functional Independence Measure scale were used for recording the outcome measures, and treatment has been demonstrated to lessen challenges and enhance health and quality of life. The rehabilitation protocol results in the improvement of posture motor control and the avoidance of secondary impairments.
Keywords: functional independence scale, rehabilitation, huges scale, physiotherapy management, guillian-barre syndrome
Introduction
Guillain-Barre syndrome (GBS) is unusual inflammatory demyelinating polyradiculoneuropathy that results from loss of motor control. The most common forms responsible for 70-80% of cases are acute motor axonal neuropathy (AMAN) and acute inflammatory demyelinating neuropathy (AIDP), and others are Miller-Fisher syndrome (MFS) and acute axonal and sensory axonal neuropathy (AMSAN), which are the variants of GBS [1]. Numerous clinical, neurophysiological, and pathological studies have suggested that acute inflammatory neuropathy primarily affects large-diameter myelinated nerves. According to a few articles, experimental allergic neuritis (EAN), which can be caused by immunizing animals, is thought to have pathological alterations in the peripheral nervous system (PNS), which is seen in GBS [2]. Patients with GBS experience sensory abnormalities like sensory ataxia, allodynia, and a reduction in sensation to thermal or nociceptive stimuli [3]. Flaccidity is seen, which initially affects the lower limbs and advances in an ascending manner; in this, the patient experiences weakness in the lower limb with tingling or numbness with the appearance of "rubber legs" or legs that buckle [4]. The primary pathogen is Campylobacter jejuni, known to be a leading cause of GBS, which influences the immune response that targets the infecting organisms and interacts with the brain tissue. AIDP is caused by an immune system reaction against Schwann cells present over the surface membrane in 85% and a response against an epitope in the axonal membrane in 15% of cases [5]. Studies have shown patients with good physical fitness suffering from GBS have a good recovery rate in mental functioning and motor control [6]. Pain is seen as prevalent in 66% of cases of acute GBS patients [7].
Physiotherapy treatment aims to accelerate recovery and lessen the severity of the condition by treating symptoms like weakness, pain, and difficulty in breathing through breathing exercises, strengthening, mobility, and postural control. Continuation of therapy will help the patient go back to her daily routine and make her functionally independent [8]. This case presents a 20-year-old with complaints of weakness in the lower extremity that progressed into flaccidity of all four limbs and severe pain in the lower limb; she was not able to perform the coordinated movement, and the management was begun by providing ventilator support and hospitalization the patients, specific immunomodulating pharmaceuticals that seem to minimize nerve damage was used, the physiotherapy rehabilitation was begun from the day of admission.
Case presentation
Patient information
A 20-year-old girl visited Acharya Vinobha Bhave Rural Hospital (AVBRH) hospital with complaints of bilateral upper limb as well as lower limb weakness; her lower limbs were more affected than her upper limbs, which started before coming to the hospital. She also complained of severe pain in her lower limb with a tingling sensation, motor dysfunction, abnormal gait and severe difficulty in walking. She gave a history of fever 15 days back. The patient had no history of ear, nose, throat bleed, hemoptysis, head trauma, or seizures and gave no relevant medical history of tuberculosis, bronchial asthma, diabetes or hypertension. Cerebrospinal fluid (CSF) investigations showed elevated protein levels (111 mg/dL) and raised white blood cell (WBC) count, confirming that the patient had GBS.
Clinical findings
The patient was conscious and cooperative, with a Glasgow coma scale (GCS) score of E4, V4, and M6. She was afebrile and hemodynamically stable. The patient's oral consent was taken. On inspection, the patient was ectomorphic. On examination, deep and superficial reflexes were diminished, as shown in Table 1. The upper and lower limbs were flaccid (Table 2). Sensations were intact. Pain assessment was done using a visual analogue scale (VAS); the findings were 7/10 at rest and 9/10 on the movement of the lower limb.
Table 1. Demonstrates the variation in reflexes grading.
0: Absent, 1+: Present but depressed, 2+: Brisk response; normal, 3+: Very response, 4+: Clonus always abnormal
| Types of reflex | Pre-intervention |
| Superficial reflexes | |
| Planter | 1+ |
| Abdominal | 1+ |
| Deep tendon reflexes | |
| Biceps | 1+ |
| Triceps | 1+ |
| Knee jerk | 1+ |
| Ankle jerk | 1+ |
Table 2. Demonstrate the variation in muscle tone (TGS).
Tone grading system (TGS): 0: No increase in tone, 1+: Decrease tone, 2+: Normal tone, 3+: Increase tone
| Muscle group | Pre-intervention |
| Shoulder flexors | 0 |
| Shoulder extensors | 0 |
| Elbow flexors | 0 |
| Hip extensors | 0 |
| Hip flexors | 0 |
| Ankle flexors | 0 |
| Ankle extensors | 0 |
Diagnostic assessment
Primarily, the weakness was seen in the distal muscle group, which later progressed to proximal muscles. Deep tendon reflexes were absent in the patient; CSF examination was performed as a diagnostic tool, which revealed an increased protein level (111 mg/dL). She was diagnosed with AIDP following the nerve conduction velocity findings, which demonstrated reduced and prolonged distal motor latency, as well as conduction velocity within normal limits in the bilateral median, ulnar, and tibial nerves. Additionally, the amplitude of the compound muscle action potential could not be elicited in the bilateral peroneal nerve. The bilateral ulnar, tibial, peroneal, and median nerves were unable to elicit F-min latency. The amplitude of the sensory nerve action potential was diminished in the bilateral median nerves and was not elicitable in the right ulnar or bilateral sural nerves.
Therapeutic intervention
After admission to the hospital, early rehabilitation was initiated. The treatment aimed to maximize neuromuscular function and to gain back patient's functional independence, thereby improving quality of life. Intravenous immunoglobulin (IVIG) was given instead of plasma exchange as the primary treatment, with a dose of 0.4/kg body weight daily for five days regularly. Relaxation was the basic pain management given. Table 3 gives a brief summary of the physiotherapy intervention received by the patient.
Table 3. Physiotherapy management .
PROM: Passive range of motion, TA: Tendo Achilles, PNF: Proprioceptive neuromuscular facilitation, Reps: Repetitions, UL: Upper limb, LL: Lower limb, Sec: Seconds, TENS: Transcutaneous electrical nerve stimulation
| Goals | Treatment protocol | Doses |
| To reduce flaccidity | PROM to UL and LL was given to the patient to mobilize the joints and minimize stiffness. | 20 reps with a break of 2 minutes. |
| To prevent contractures | Passive contract-relax stretches were given to TA. | 2 sets of 10 reps each with 30 sec of hold and 5 sec of release. |
| To normalize the muscle tone | PNF techniques for both UL and LL were given. | Contract relax technique is given for 10 reps in 1 set. |
| To improve muscle strength | A combination of isometric and rhythmic stabilization was given to LL, dynamic quadriceps. | 10 reps in 1 set. |
| To alleviate tingling sensation | TENS | 10 mins, 2 times per day. |
| To prevent respiratory complications | Segmental breathing and pursed lip breathing exercises. | 10 reps of each exercise. |
| To enhance functional status and bed mobility | Supine-to-sit transition training with rolling facilitation. | Employing upper extremity momentum and crossing the ankles to roll from a supine position to a side-lying position, transition training from supine to sitting with prone on the elbows from prone on the elbow to long sitting, use elbow walking, supine on the elbow. |
Figure 1 shows the patient performing dynamic quadriceps.
Figure 1. Dynamic Quadriceps.
Follow-up and outcome measures
The ultimate result of neurorehabilitation was to see improvement in a 20-year-old patient suffering from GBS at the end of the session, which is summarized in Table 4-6 below. The outcome measures used are summarized in Table 7.
Table 4. Demonstrates the variation in reflexes grading.
0: Absent, 1+: Present but depressed, 2+: Brisk response; normal, 3+: Very response, 4+: Clonus always abnormal.
| Types of reflex | Post-intervention (Day 30) |
| Superficial reflex | |
| Planter | 2+ |
| Abdominal | 2+ |
| Deep tendon reflexes | |
| Biceps | 2+ |
| Triceps | 2+ |
| Knee | 2+ |
| Ankle | 2+ |
Table 6. Demonstrates the grades of manual muscle testing (MMT).
0: No contraction with flickering contraction, 2: Full range of motion (ROM) with gravity elimination, 3: Full ROM against gravity, 4: Full ROM against gravity, moderate resistance, 5: Full ROM against gravity, maximum resistance
| Extremity | Pre-intervention (Day 1) | Post-intervention (Day 30) |
| Upper Extremity | 1/5 | 4/5 |
| Lower Extremity | 1/5 | 4/5 |
Table 7. Outcome measures.
Huges scale grading: 0: Normal, 1: Slight clinical symptom, 2: Able to walk 5m or more without assistance but unable to run, 3: Able to walk 5m with help, 4: Bedridden or chair bound, 5: Ventilator assisted breathing, 6: Death.
NPRS: Numerical pain rating scale
| Outcome measures | Pre-intervention (Day 1) | Post-intervention (Day 30) |
| Huges scale | 4 | 2 |
| NPRS scale | 8 | 5 |
| Functional independence scale | 65/120 | 105/120 |
Table 5. Demonstrates the variation in muscle tone (TGS).
Tone grading system (TGS): 0: No increase in tone, 1+: Decrease tone, 2+: Normal tone, 3+: Increase tone
| Muscle group | Post-intervention (Day 30) |
| Shoulder flexors | 2 + |
| Shoulder extensors | 2 + |
| Elbow flexors | 2 + |
| Hip extensors | 2 + |
| Hip flexors | 2 + |
| Ankle flexors | 2 + |
| Ankle extensors | 2 + |
Discussion
GBS is an auto-immune disorder that affects nerves and how they function in the body; however, this case study intended to show how physical rehabilitation has been beneficial for patients suffering from GBS. In this case, improvement is seen as the primary outcome, which also provides additional proof of the patient's recovery with IVIG treatment [9,10] and prolonged exercise [11]. Physical therapy, like massage and relaxation, helped a lot with pain management [12]. IVIG was preferred over the plasma exchange therapy [13,14].
Moreover, proprioceptive neuromuscular facilitation (PNF) techniques have shown quick improvement and have increased neuromuscular efficiency [15,16]. Chest physiotherapy and frequent position changing Franklin's exercises were performed to increase the efficiency of movement, with less risk of injury [17]. Khan et al. carried out a study on outcome measures of low-intensity rehabilitation programs in the acute phase, which showed good results and reduced the disability in patients suffering from GBS in later stages. This also showed a good result in this case. The investigations showed a high protein level and normal white blood cell count, which was done on cerebrospinal fluid, conforms to the diagnosis of GBS [18,19]. Moreover, the patient, after the pro-long duration of treatment, can perform mild exercises that do not require a large amount of strength or endurance [20]. The patient's quality of life and functional outcome were elevated, showing the positive result of physiotherapy treatment. Thus, this case study illustrates how physiotherapy significantly enhances strength, daily living activities and quality of life.
Conclusions
In conclusion, the physiotherapy intervention in this GBS case report demonstrated notable effectiveness. The patient exhibited improvement in motor function, increased strength, respiratory function and enhanced overall mobility. This case report suggests that early and targeted physiotherapy intervention can contribute significantly to the recovery and quality of life for patients. These positive outcomes underscore the valuable role of physiotherapy in managing Guillain-Barre syndrome, emphasizing its significance in the holistic care and rehabilitation of affected individuals.
The authors have declared that no competing interests exist.
Author Contributions
Concept and design: Ishwari Gawande, Aditi Akhuj, Snehal Samal
Acquisition, analysis, or interpretation of data: Ishwari Gawande, Aditi Akhuj, Snehal Samal
Drafting of the manuscript: Ishwari Gawande, Aditi Akhuj, Snehal Samal
Critical review of the manuscript for important intellectual content: Ishwari Gawande, Aditi Akhuj, Snehal Samal
Supervision: Aditi Akhuj, Snehal Samal
Human Ethics
Consent was obtained or waived by all participants in this study
References
- 1.Emphasis on the optimal functional recovery through a structured in patient rehabilitation program along with a home exercise regime in an individual with miller-fisher syndrome: a case report. Boob MA, Dadgal R, Salphale VG. Cureus. 2022;14:0. doi: 10.7759/cureus.29919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review. [ Nov; 2023 ];Honavar M, Tharakan JK, Hughes RA, Leibowitz S, Winer JB. Brain. 1991 114 ( Pt 3):1245–1269. doi: 10.1093/brain/114.3.1245. [DOI] [PubMed] [Google Scholar]
- 3.Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations. [ Nov; 2023 ];Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST. Brain. 2003 126:386–397. doi: 10.1093/brain/awg039. [DOI] [PubMed] [Google Scholar]
- 4.Guillain-Barré syndrome: epidemiology, pathophysiology and management. Kuwabara S. Drugs. 2004;64:597–610. doi: 10.2165/00003495-200464060-00003. [DOI] [PubMed] [Google Scholar]
- 5.Guillain-Barré syndrome. Shahrizaila N, Lehmann HC, Kuwabara S. Lancet. 2021;397:1214–1228. doi: 10.1016/S0140-6736(21)00517-1. [DOI] [PubMed] [Google Scholar]
- 6.Influence of exercise on patients with guillain-barré syndrome: a systematic review. [ Nov; 2023 ];Simatos Arsenault N, Vincent PO, Yu BH, Bastien R, Sweeney A. Physiother Can. 2016 68:367–376. doi: 10.3138/ptc.2015-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Diagnosis and management of Guillain-Barré syndrome in ten steps. [ Nov; 2023 ];Leonhard SE, Mandarakas MR, Gondim FA, et al. Nat Rev Neurol. 2019 15:671–683. doi: 10.1038/s41582-019-0250-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. [ Aug; 2024 ];Rahimi K. Neurol Sci. 2020 41:3149–3156. doi: 10.1007/s10072-020-04693-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Guillain-barré syndrome. Panesar K. https://www.uspharmacist.com/article/guillain-barre-syndrome Neurology. 2014;39:35–38. [Google Scholar]
- 10.The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. [ Nov; 2023 ];Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. Neurology. 1998 51:1110–1115. doi: 10.1212/wnl.51.4.1110. [DOI] [PubMed] [Google Scholar]
- 11.Clinical features, pathogenesis, and treatment of guillain-barré syndrome. Doorn PA, Ruts L, Jacobs BC. Lancet Neurol. 2008;7:939–950. doi: 10.1016/S1474-4422(08)70215-1. [DOI] [PubMed] [Google Scholar]
- 12.Intensive care and treatment of severe guillain-barré syndrome. Shang P, Feng J, Wu W, Zhang HL. Front Pharmacol. 2021;12:608130. doi: 10.3389/fphar.2021.608130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Guillain-Barré syndrome. Newswanger DL, Warren CR. https://pubmed.ncbi.nlm.nih.gov/15168961/ Am Fam Physician. 2004;69:2405–2410. [PubMed] [Google Scholar]
- 14.Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. https://www.tandfonline.com/doi/abs/10.1080/1744666X.2016.1193006. Expert Rev Clin Immunol. 2016;12:1175–1189. doi: 10.1080/1744666X.2016.1193006. [DOI] [PubMed] [Google Scholar]
- 15.The PNF (proprioceptive neuromuscular facilitation) stretching technique - a brief reviews. Victoria GD, Carmen EV, Alexandru S, Antoanela O, Florin C, Daniel D. https://d1wqtxts1xzle7.cloudfront.net/77305354/86-libre.pdf?1640416844=&response-content-disposition=inline%3B+filename%3DThe_PNF_Proprioceptive_Neuromuscular_Fac.pdf&Expires=1701167830&Signature=NCKuvUY-L3iQ-6wVP7IirAkpytLhL27xYX4i2OAQgA-xBpub35nT4qgsZlLnpSNx1nGudE1vUH-SBNNB4joTAFqJG9Mv8UAKq~QJ2fQnc5EciXNC4ee4yxt2llGKhG4XMiT8FF8OsXHMlKS2foaK8YGyAqc9~nD1VjRQM0M9hCtgnoQ8y1Fvv2c4a1bZgaMrFaoDStBImF3cvZ3k0QdgJqbVGo3kCV9Z9EHFFQWj9n5LulaEbZ41kfW3RUYMn2M5-izoYnwisC6JA-5jvLJl-v~StR6IxfWIsxlMOIFbNqnHNdiLCO2AFNoNo8qPI--IEjUivKIOqWWMuG-Z~TGqbg__&Key-Pair-Id=APKAJLOHF5GGSLRBV4ZA Sci Mov Health. 2013;13:623–628. [Google Scholar]
- 16.Effectiveness of high and low intensity rehabilitation programme in chronic phase of guillain barre syndrome patients: a randomized control trail. [ Nov; 2023 ];Kumar G, Arora L, Arora R. https://oapub.org/hlt/index.php/EJPRS/article/view/53 Eur J Physiother Rehabil Stud. 2021 1:1–8. [Google Scholar]
- 17.Guillain-barre syndrome and other acute polyneuropathies. Kwan J, Biliciler S. Clin Geriatr Med. 2021;37:313–326. doi: 10.1016/j.cger.2021.01.005. [DOI] [PubMed] [Google Scholar]
- 18.Residual disability 10 years after falling ill in Guillain-Barré syndrome: a prospective follow-up study. Forsberg A, Press R, Holmqvist LW. J Neurol Sci. 2012;317:74–79. doi: 10.1016/j.jns.2012.02.026. [DOI] [PubMed] [Google Scholar]
- 19.Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease. [ Nov; 2023 ];de Vries JM, Hagemans ML, Bussmann JB, van der Ploeg AT, van Doorn PA. Cell Mol Life Sci. 2010 67:701–713. doi: 10.1007/s00018-009-0184-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Residual subclinical impairment in patients who totally recovered from Guillain-Barré syndrome: impact on military performance. [ Nov; 2023 ];Burrows DS, Cuetter AC. Mil Med. 1990 155:438–440. [PubMed] [Google Scholar]

